Celmatix Obtains Series A Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    7 Hubert Street New York, NY 10013
  • Company Description
    Celmatix, Inc. is a New York City-based biotechnology company targeting the reproductive medicine sector with products designed to improve reproductive technologies and outcomes. Our lead product under development is FertilArrayTM, an in vitro genetic diagnostic for assessing female egg quality and genetic indicators of female infertility.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Celmatix will use the Series A financing to continue Research and Development for their proposed egg quality diagnostic, FertilArray.
  • M&A Terms
  • Venture Investor
    Topspin Partners